NCT01327261View on ClinicalTrials.gov

Fasting Comparative Bioavailability of Two Tablet Formulations of Levodopa /Benserazide in Healthy Volunteers

PHASE4CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

December 31, 2009

Conditions

Healthy Volunteers

Interventions

DRUG

Levodopa + benserazide

Single oral dose of either Experimental or Active Comparator. Levodopa 200 mg/benserazide 50 mg tablets,with 200 mL of water.

Sponsors

Collaborators (1)

Laboratorios Phoenix S.A.I.C.y F.

All Listed Sponsors

collaborator

Laboratorios Phoenix S.A.I.C.y F.

UNKNOWN

lead

University of Buenos Aires

OTHER